ResApp Health Signs LOI to launch diagnostic app in the Philippines
- ResApp Health’s (RAP) smartphone diagnostic test is set to launch in the Philippines through an agreement with telehealth company Homify
- Homify was founded last year and plans to launch with ResApp’s smartphone-based acute respiratory diagnostic test, ResAppDx, as a foundational diagnostic support tool
- The parties have signed a letter of intent agreement which is conditional on Homify being approved to operate a telehealth business in the Philippines
- ResApp will also need regulatory approval for the test as a medical device in the Philippines before the launch can take place
- Shares are up 1.67 per cent at 6.1 cents at 3.45pm AEDT
